PETALING JAYA, Oct. 16 -- Universiti Malaya Medical Centre (UMMC) has reached a new milestone in clinical research with the establishment of its Phase I Unit, which will conduct early-stage drug and device trials under hospital conditions.

The facility, located at the UMMC's Clinical Investigation Centre (CIC), is the first of its kind in a Malaysian teaching hospital and is designed for First-in-Human and Phase I studies focusing on safety, tolerability and dosage.

UMMC Hospital Director Professor Dr Nazirah binti Hasnan said the unit strengthens the hospital's role in training doctors, researchers and students, giving them invaluable hands-on experience in the complexities of early-phase clinical research.

"For patients, it means the...